| A股股票代码：601336 | A股股票简称：新华保险 编号：2025-014号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 第七届监事会第五十三次会议决议公告 新华人寿保险股份有限公司监事会及全体监事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2025 年 3 月 17 日以电 子邮件方式向全体监事发出第七届监事会第五十三次会议（以下简称"会议"） 通知和材料，会议于 2025 年 3 月 27 日在北京市以现场会议方式召开。会议应到 监事 4 人，现场出席监事 4 人。会议的召集、召开符合《中华人民共和国公司法》 《新华人寿保险股份有限公司章程》（以下简称"《公司章程》"）和《新华人寿保 险股份有限公司监事会议事规则》的有关规定，所作的决议合法、有效。 会议由公司监事长刘德斌主持，经与会监事审议和现场表决，形成如下会议 决议： 一、审议通过了《关于 2024 年年度报告（A 股/H 股）的议案》，同意将议 案提 ...

A股股票代码：601336 A股股票简称：新华保险 编号：2025-013号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 第八届董事会第三十一次会议决议公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2025 年 3 月 13 日以电 子邮件方式向全体董事发出第八届董事会第三十一次会议（以下简称"会议"） 通知和材料，会议于 2025 年 3 月 27 日在北京市以现场方式召开。会议应到董事 10 人，现场出席董事 10 人，公司监事和高级管理人员列席了会议。会议的召集、 召开符合《中华人民共和国公司法》《新华人寿保险股份有限公司章程》和《新 华人寿保险股份有限公司董事会议事规则》的有关规定，所作的决议合法、有效。 会议由公司董事长杨玉成主持，经与会董事审议和现场表决，形成如下会议 决议： 一、审议通过了《关于分红业务 2024 年度红利分配方案的议案》。 表决情况：同意 10 票，反对 0 票，弃权 0 票。 二、审议 ...

Financial Performance - The company achieved a total operating revenue of CNY 170.51 billion in 2024, representing a year-on-year growth of 2.8%[26]. - The net profit attributable to shareholders was CNY 26.23 billion, marking a remarkable growth of 201.1% year-on-year, reaching a historical high[26]. - The company achieved original insurance premium income of 170.5 billion yuan in 2024, with total assets reaching 1.69 trillion yuan, indicating stable overall operations[41]. - The company reported a total investment income of 16,306 million RMB, a substantial recovery from a loss of 3,775 million RMB in 2023[71]. - The total investment return rate improved to 5.8%, up by 4.0 percentage points from 1.8% in 2023[114]. - The company’s basic earnings per share rose to 8.41 RMB, marking a 201.4% increase from 2.79 RMB in 2023[61]. - The company’s total equity attributable to shareholders decreased by 8.4% to 96,240 million RMB, primarily due to increased losses recognized in other comprehensive income[60]. - The company’s operating revenue for 2024 reached 132,555 million RMB, an increase of 85.3% compared to 71,547 million RMB in 2023[59]. - Net profit attributable to shareholders of the parent company surged to 26,229 million RMB, reflecting a 201.1% increase from 8,712 million RMB in the previous year[59]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 1.99 per share for the year-end, totaling CNY 62.08 billion, which, along with the mid-year dividend of CNY 0.54 per share, brings the total cash dividends for 2024 to CNY 78.93 billion, accounting for approximately 30.1% of the net profit attributable to shareholders[5]. - The company plans to distribute a total cash dividend of CNY 78.93 billion for 2024, an increase of 197.6% compared to the previous year[25]. - The company plans to distribute a total dividend of CNY 7.893 billion for the year, accounting for 30.1% of net profit attributable to shareholders[53]. Risk Management - The company has identified several risks, including market risk, credit risk, insurance risk, operational risk, reputational risk, strategic risk, and liquidity risk, and has implemented measures to manage and control these risks effectively[5]. - The company anticipates facing risks due to complex international environments and ongoing industry adjustments, necessitating continuous risk monitoring[148]. - The company will optimize its comprehensive risk management system to ensure effective operation and compliance with regulatory standards[148]. Corporate Governance - The financial report for 2024 has been audited by Deloitte Huayong, which issued a standard unqualified audit opinion[5]. - The company’s chairman and senior management have guaranteed the accuracy and completeness of the financial report[5]. - The company has no violations of decision-making procedures regarding external guarantees[5]. - The company has no instances of more than half of the directors being unable to ensure the authenticity of the report[5]. - The company is actively working on compliance with regulatory requirements regarding board member qualifications and appointments[187]. Product and Service Development - The company launched multiple service brands, including "新华尊" and "新华安," to enhance customer experience across various sectors[29][30]. - The company launched 58 new insurance products in 2024, enhancing its offerings in health, retirement, accident, medical, and wealth management insurance[92]. - The company has established a digital service chain that includes features like "digital human" product explanations and intelligent product recommendations, enhancing customer experience[37]. - The company has developed a collaborative model of "insurance + service + investment," managing nearly 2 trillion yuan in assets through its asset management platform[42]. Investment and Asset Management - The total investment assets increased to CNY 1,629.36 billion, up from CNY 1,345.48 billion in 2023, reflecting a strong growth in investment capabilities[18]. - The investment return rate for 2024 was reported at 5.8%, with a comprehensive investment return rate of 8.5%[28]. - The company plans to leverage its long-term capital advantages to support the real economy and enhance investment returns through strategic asset allocation[105]. - The company has established a service framework to support national strategies, with an investment scale of CNY 1,088.8 billion in the real economy[24]. Human Resources and Talent Development - The company launched the "XIN Generation" talent development project in 2024, resulting in a significant increase in the number of IDA members by over 100% year-on-year[33]. - The company’s board of directors has undergone several changes, including the appointment of new assistant presidents Liu Chen and Liu Zhiyong in early 2024[190]. Compliance and Regulatory Matters - The company does not face any non-operational fund occupation by controlling shareholders or related parties[5]. - The company has no violations of decision-making procedures regarding external guarantees[5]. - The company is in the process of finalizing the annual performance bonuses for employee representatives and senior management for 2024[190]. Market Position and Recognition - The company has been recognized as one of the top 50 most valuable insurance brands globally for 10 consecutive years and has received an "A2" financial strength rating from Moody's in 2024[39][45]. - The company emphasizes the importance of high-quality development in the insurance industry, aligning with national policies for sustainable growth[145].

重要内容提示： 每股派发现金红利人民币 1.99 元（含税）。 本次利润分配以实施权益分派股权登记日登记的总股本为基数，具体 日期将在权益分派实施公告中明确。 本次利润分配方案尚待公司 2024 年年度股东大会审议通过后方可实 施。 A股股票代码：601336 A股股票简称：新华保险 编号：2025-015号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 2024年年度利润分配方案公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任何 虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 本次利润分配方案不触及《上海证券交易所股票上市规则（2024 年 4 月修订）》（以下简称《股票上市规则》）第 9.8.1 条第一款第（八）项规定的可能 被实施其他风险警示的情形。 一、利润分配方案内容 （一）利润分配方案的具体内容 经德勤华永会计师事务所（特殊普通合伙）审计，新华人寿保险股份有限公 司（以下简称"公司"）2024年度母公司财务报表净利润为252.02亿元（人民币， 下同），合并财务报表归属于母公司股东的净利润为262.29亿元。 ...

智通财经APP讯，新华保险(01336)公布2024年业绩，公司寿险业务结构和业务品质持续优化，规模和价 值实现全面增长。全年实现原保险保费收入1,705.11亿元，同比增长2.8%;收入合计1320.44亿元，同比 增长82.7%。一年新业务价值62.53亿元，同比增长106.8%;首年保费口径下新业务价值率14.6%，较2023 年的 6.7%提高7.9个百分点;实现归属于母公司股东的净利润262.29亿元，较上年增长201.1%，达到历史 新高。末期现金股利每股1.99元(含税)。 公告称，净利增长主要受资本市场上涨的影响，2024年投资业绩同比增长。2024年，公司投资组合综合 投资收益率为8.5%，总投资收益率为5.8%，净投资收益率为3.2%。 2024年，公司业务结构持续优化。长期险首年期交保费占长期险首年保费比例为70.1%，较上年同期提 升 12.6个百分点;十年期及以上期交保费占长期险首年期交保费比例为12.6%，较上年同期有所提升;续 期保费占总保费的比例为75.0%，"压舱石"作用稳固。传统险和分红险长期险首年保费占长期险首年保 费比例合计96.5%，占比保持稳定。 2024年，公司深 ...

A股股票代码：601336 A股股票简称：新华保险 编号：2025-012号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 关于召开2024年度业绩发布会的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 重要内容提示： 二、业绩发布会召开的时间、地点 （三）网络直播地址：https://s.comein.cn/79gjiqe1 三、本公司出席人员 本公司董事长杨玉成，总裁、首席财务官龚兴峰，副总裁秦泓波，副总裁王 1 会议召开时间：2025 年 3 月 28 日（星期五）15:00-16:30 会议召开方式：网络直播 网络直播地址：https://s.comein.cn/79gjiqe1 投资者可于 2025 年 3 月 24 日（星期一）23:59 前将相关问题通过电子邮 件的形式发送至新华人寿保险股份有限公司（以下简称"本公司"）投资者 关系邮箱：ir@newchinalife.com。 一、业绩发布会类型 本公司拟于 2025 年 3 月 28 日在上海证券交易所 ...

Investment Rating - The report maintains a "Recommended" rating for the non-bank financial sector, indicating a rapid recovery in valuations [2][3]. Core Insights - The report highlights a strong performance in the insurance sector, with specific companies like Ping An and China Pacific showing significant growth potential [10]. - The brokerage sector is experiencing a valuation recovery, with notable increases in stock prices and earnings per share (EPS) forecasts for key players [10]. - The overall market sentiment is improving, with the insurance index outperforming the broader market, suggesting a favorable environment for investment in this sector [6][10]. Summary by Sections Key Company Profit Forecasts, Valuation, and Investment Ratings - China Ping An: EPS forecast for 2024E is 6.91, with a strong buy recommendation [4]. - China Pacific: EPS forecast for 2024E is 4.41, with a recommended rating [4]. - New China Life: EPS forecast for 2024E is 7.87, with a recommended rating [4]. - Guotai Junan: EPS forecast for 2024E is 1.09, with a recommended rating [4]. - CITIC Securities: EPS forecast for 2024E is 1.47, with a recommended rating [4]. - Huatai Securities: EPS forecast for 2024E is 1.73, with a recommended rating [4]. Market Performance - The brokerage index increased by 2.95%, underperforming the broader market by 1.37 percentage points, while the insurance index rose by 4.35%, outperforming the market by 2.76 percentage points [10]. - The average daily trading volume in the market was 16,557.35 billion, showing a slight decrease [10]. - The total market capitalization of the non-bank financial sector reached 52,964.03 billion, with a circulating market value of 39,161.16 billion [5]. Valuation Metrics - The report indicates that the current price-to-earnings (PE) ratio for the brokerage sector is around 1.58x, while the insurance sector stands at 1.38x [33]. - The report also notes that the price-to-book (PB) ratio for key companies in the sector is showing signs of recovery, with Ping An at 1.03x and China Pacific at 1.12x [4][33]. Investment Recommendations - The report recommends focusing on companies such as Ping An, China Pacific, New China Life, and Guotai Junan for potential investment opportunities [3][10]. - It suggests that investors pay attention to the performance of China Reinsurance and other emerging players in the insurance market [10].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report emphasizes the expansion of market hotspots towards cyclical industries such as large consumption and finance, highlighting opportunities in the non-bank financial sector. The market's trading activity remains high, and with low investment returns as a baseline, it is expected that brokerage firms will see significant year-on-year growth in Q1 performance. The report maintains a positive outlook on brokerage and fintech sectors, while the insurance sector shows stable liabilities and potential for equity beta catalysts [5][11]. Summary by Sections 1. Capital Market Support for Technological Innovation - The central bank's recent meeting emphasized the implementation of a moderately loose monetary policy, with potential interest rate cuts. Following this, the non-bank financial sector saw a notable increase of 3.97% on March 14. The report suggests that the brokerage sector is likely to experience high growth in Q1 due to increased trading volumes and a favorable investment environment [5][11]. 2. Market Review - During the trading days from March 10 to March 14, the non-bank sector outperformed the CSI 300 index, with a gain of 3.15%. Notably, brokerage firms and insurance companies increased by 2.86% and 4.29%, respectively. Key stocks such as New China Life and China Pacific Insurance saw significant increases of 11.2% and 5.7% [16][17]. 3. Data Tracking - The average daily trading volume for stock-based funds was 1.92 trillion yuan, a decrease of 3% week-on-week but an increase of 65% year-on-year. The report also notes a significant increase in the issuance of public funds, with 167 new stock and mixed funds issued in 2025, totaling 883 billion yuan, which is a 111% year-on-year increase [20][21]. 4. Industry and Company News - The report highlights the upcoming public fund reform plan, which is expected to introduce significant new regulations affecting the 32 trillion yuan public fund market. Key changes include a shift towards long-term performance assessments for fund managers and adjustments to fee structures [31]. Additionally, the report mentions the release of regulatory guidelines for the bankruptcy restructuring of listed companies [32]. 5. Recommended and Beneficiary Stocks - The report recommends stocks such as Hong Kong Exchanges, Dongfang Securities, and China Life Insurance, while also identifying beneficiary stocks including Nine Point Investment Holdings and China Galaxy Securities [14].

将投中网设为"星标⭐"，第一时间收获最新推送 捕捉LP圈一周商业情报。 作者丨王满华 来源丨投中网 如今都说募资难，特别是募市场化LP的钱更是难于上青天。 除了工行的消息外，据投中网不完全统计，本周LP圈共有16条动态，推荐关注中国人寿发起设立的 鸿鹄基金二期、湖南建投集团发起的30亿元产业母基金、紫金港资本海宁海愿基金，以及30亿规模 的江苏省节能环保战新产业基金。 新基金 工商银行启动800亿元科技创新基金 2025年3月12日，中国工商银行与全国工商联在北京联合举办"金融助企 提质向新"金融赋能民营企业 高质量发展推进会，会议现场举办了工商银行科技创新基金启动仪式。该基金总规模800亿元，定位 耐心资本，以股为主，股债贷保联动，将持续加大对硬科技、民营经济的支持，为实体经济注入股权 投资力量。 首只险资私募证券基金已投资落地500亿元，获批设立二期基金 为了解决这一难题，近一年来，鼓励市场化资金参与股权投资的政策频出，特别是如何有序引导银行 加大对科技创新和创业投资的支持力度，一直是有关部门的工作重点。 2024年9月，金融监管总局发布《关于扩大金融资产投资公司股权投资试点范围的通知》，给银行系 资金入 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對本通告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 承董事會命 新華人壽保險股份有限公司 楊玉成 董事長 中國北京，2025 年 3 月 14 日 於本通告日期，本公司董事長、執行董事為楊玉成；執行董事為龔興峰；非執 行董事為何興達、楊雪、胡愛民和李琦強；及獨立非執行董事為馬耀添、賴觀 榮、徐徐和郭永清。 董事會會議通告 新華人壽保險股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈， 本公司將於二零二五年三月二十七日（星期四）舉行董事會會議，藉以(其中包 括)考慮及批准本公司及其附屬公司截至二零二四年十二月三十一日止年度的業 績及其發佈，並考慮派發末期股息，以及處理其他事項。 [公司商標] 新華人壽保險股份有限公司 ...